Citius Pharmaceuticals Statistics
Total Valuation
CTXR has a market cap or net worth of $17.10 million. The enterprise value is $18.00 million.
Important Dates
The next estimated earnings date is Monday, August 11, 2025, after market close.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CTXR has 11.17 million shares outstanding. The number of shares has increased by 19.89% in one year.
Current Share Class | 11.17M |
Shares Outstanding | 11.17M |
Shares Change (YoY) | +19.89% |
Shares Change (QoQ) | +14.53% |
Owned by Insiders (%) | 6.75% |
Owned by Institutions (%) | 5.32% |
Float | 10.42M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 0.95 |
PS Ratio | n/a |
Forward PS | 0.35 |
PB Ratio | 0.22 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.01.
Current Ratio | 0.37 |
Quick Ratio | 0.00 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.53% and return on invested capital (ROIC) is -37.09%.
Return on Equity (ROE) | -60.53% |
Return on Assets (ROA) | -25.32% |
Return on Invested Capital (ROIC) | -37.09% |
Return on Capital Employed (ROCE) | -60.03% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.87M |
Employee Count | 23 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CTXR has paid $816,480 in taxes.
Income Tax | 816,480 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.16% in the last 52 weeks. The beta is 0.85, so CTXR's price volatility has been lower than the market average.
Beta (5Y) | 0.85 |
52-Week Price Change | -90.16% |
50-Day Moving Average | 0.88 |
200-Day Moving Average | 4.14 |
Relative Strength Index (RSI) | 68.44 |
Average Volume (20 Days) | 6,723,968 |
Short Selling Information
The latest short interest is 1.35 million, so 12.07% of the outstanding shares have been sold short.
Short Interest | 1.35M |
Short Previous Month | 664,615 |
Short % of Shares Out | 12.07% |
Short % of Float | 12.94% |
Short Ratio (days to cover) | 0.27 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -42.98M |
Pretax Income | -39.78M |
Net Income | -43.10M |
EBITDA | -42.98M |
EBIT | -42.98M |
Earnings Per Share (EPS) | -$5.70 |
Full Income Statement Balance Sheet
The company has $26,410 in cash and $931,795 in debt, giving a net cash position of -$905,385 or -$0.08 per share.
Cash & Cash Equivalents | 26,410 |
Total Debt | 931,795 |
Net Cash | -905,385 |
Net Cash Per Share | -$0.08 |
Equity (Book Value) | 63.58M |
Book Value Per Share | 6.92 |
Working Capital | -31.50M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -23.55M |
Capital Expenditures | n/a |
Free Cash Flow | -23.55M |
FCF Per Share | -$2.11 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CTXR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -19.89% |
Shareholder Yield | -19.89% |
Earnings Yield | -252.07% |
FCF Yield | -137.72% |
Analyst Forecast
The average price target for CTXR is $53.00, which is 3,364.05% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $53.00 |
Price Target Difference | 3,364.05% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 26, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Nov 26, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |